BOLD
USDBoundless Bio Inc. Common Stock
Reaalajas hind
Hinnagraafik
Põhinäitajad
Turunäitajad
Avatud
$1.170
Kõrge
$1.195
Madal
$1.150
Maht
0.20M
Ettevõtte fundamentaalnäitajad
Turukapitalisatsioon
26.9M
Tööstusharu
Biotehnoloogia
Riik
United States
Kauplemisstatistika
Keskmine maht
0.17M
Börs
NMS
Valuuta
USD
52 nädala vahemik
Seotud uudised
Boundless Bio to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference
SAN DIEGO, June 05, 2025 (GLOBE NEWSWIRE) -- Boundless Bio (NASDAQ:BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to patients with
Leerink Partners Downgrades Boundless Bio to Market Perform, Lowers Price Target to $3
Leerink Partners analyst Michael Cherny downgrades Boundless Bio from Outperform to Market Perform and lowers the price target from $15 to $3.
Boundless Bio Announces Portfolio Prioritization and Runway Extension
Portfolio prioritization focuses on novel-novel combination therapy of BBI-355 and BBI-825 and new development candidate, BBI-940, for novel kinesin program Operating runway extended into the first half of 2028, through
Seotud aktsiad
SNCRL
Synchronoss Technologies Inc. 8.375% Senior Notes due 2026
SLN
Silence Therapeutics Plc American Depository Share
GRDI
GRIID Infrastructure Inc.
VCEL
Vericel Corporation
AQN
Algonquin Power & Utilities Corp. Common Shares
Püsi kursis
Määrake hinnateavitused, hankige tehisintellekti analüüsi uuendusi ja reaalajas turuuudiseid.